MR-61 eye drops for slowing nearsightedness in children
Part of Eyes & vision clinical trials.
This trial tests an eye drop called MR-61 to see if it can slow down worsening nearsightedness (myopia) in children and teens. The study aims to find a safe and easy way to keep their vision from getting worse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 3 and 18 years old.
- You have been diagnosed with nearsightedness (myopia) in both eyes.
- You have not worn special contact lenses or glasses for myopia control before.
- You have healthy eyes, with no other eye diseases.
- Your vision with glasses or contacts is good (20/20 or better).
- You have not used certain medications or treatments for myopia, like low-dose atropine or red-light therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests special glasses with 3D defocus lenses to slow down the progression of myopia (nearsightedness) in children and teens. It aims to see if these lenses are more effective than standard glasses at preventing vision from getting worse.
This trial tests a special eyeglass lens designed to slow down the worsening of nearsightedness (myopia) in children ages 6 to 14. It aims to keep their eyesight from getting worse quickly.
This study tests a new eye drop medicine (T10430) to see if it can slow down how fast children's nearsightedness gets worse. The trial will measure whether the drops are safe and effective for kids ages 6–11.
This trial tests whether brimonidine eye drops can slow down worsening nearsightedness (myopia) in children. It aims to find a non-invasive way to help prevent vision from getting more nearsighted.
This study tests an experimental eye drop called IVMED-85 to see if it can slow down or stop the progression of nearsightedness (myopia) in children and teenagers. If it works, it might help keep their vision from getting worse as they grow.
This study tests an eye drop (QLM3004) to see if it can slow down the progression of nearsightedness (myopia) in children. It might be a good option if your child is between 6 and 12, has mild to moderate nearsightedness, and hasn't used other myopia treatments before.
Hear when a new Myopia Progressing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.